# GLAXO share price, delivery % and history — GlaxoSmithKline Pharmaceuticals Limited

> Delivery percentage for GlaxoSmithKline Pharmaceuticals Limited (GLAXO) against its own history, with 7,849 sessions of split-adjusted NSE data from 1995 — plus moving averages, RSI and the 52-week range.

Canonical: https://patternsradar.com/s/GLAXO

NSE · equity · [Healthcare](https://patternsradar.com/stocks/sector/healthcare.md) · [Pharmaceuticals & Biotechnology](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md)

## Latest session

- Close: 2,769.3 INR (-0.52% on the day), 2026-09-30
- Delivery: 54.78% of volume taken to demat (20-day average 49.26%)
- Volume: 45.8K shares, turnover ₹12.7Cr
- Relative volume: 0.58× of its own 20-day average

## Technicals

- RSI(14): 42.95
- ATR(14): 86.76
- SMA 50: 2,797.09, SMA 200: 2,510.28
- 52-week range: 2,088.1 – 3,120.7 (-11.26% from the high)

## Performance

- 1 week -3.74%, 1 month -9.21%, 3 months 14.63%
- 6 months 22.56%, 1 year 0.28%

## Delivery percentage

- Latest: 54.78% (2026-09-30)
- 20-day average: 49.26%
- 1-year average: 57.54%
- Percentile against its own history: 41th
- Range: 8.44% – 96.63% across 1,728 sessions with a reading

Over the last 20 sessions GLAXO settled 49.3% of its traded quantity, which is above average for an NSE equity. Its one-year average is 57.5%, so recent sessions are running 8.3 points lower than usual. The latest session ranks higher than 41% of the 1,728 sessions on record for it.

[What delivery percentage measures](https://patternsradar.com/learn/delivery-percentage.md). [Scan the whole market on delivery](https://patternsradar.com/scans/delivery.md).

## Fundamentals

- Market cap: 46,913.6 crore
- P/E (TTM): 43.92 — NULL when trailing earnings are negative or unfiled, never a misleading number
- EPS (TTM): 63.05 INR, split-adjusted to match the price series
- Revenue growth: 16.55% YoY, -5.71% QoQ
- Profit growth: 15.69% YoY, -14.64% QoQ

Compound annual growth, trailing-twelve-month against the same measure N years earlier:

| Window | Revenue | Profit |
| --- | --- | --- |
| 2y | 6.2% | 29.19% |
| 3y | 6.56% | 19.65% |
| 5y | 3.44% | 23.73% |
| 6y | 4.23% | 50.89% |

## Quarterly results

Last 8 filed quarters, consolidated basis, in rupees crore as filed.

| Quarter | Revenue | Total expenses | Profit before tax | Net profit | EPS | Net margin |
| --- | --- | --- | --- | --- | --- | --- |
| 2024-09-30 | 1,010.8 | 706.2 | 343.8 | 252.5 | 14.67 | 24.98% |
| 2024-12-31 | 949.4 | 676.4 | 308.1 | 229.9 | 13.57 | 24.21% |
| 2025-03-31 | 974.4 | 656.5 | 358.6 | 262.9 | 15.52 | 26.98% |
| 2025-06-30 | 805.2 | 569.9 | 279 | 205 | 12.1 | 25.46% |
| 2025-09-30 | 979.9 | 662.2 | 354 | 257.5 | 15.07 | 26.28% |
| 2025-12-31 | 1,041.3 | 691.4 | 399.9 | 295.6 | 16.54 | 28.39% |
| 2026-03-31 | 995.3 | 658.2 | 373.1 | 277.9 | 16.4 | 27.92% |
| 2026-06-30 | 938.4 | 659.8 | 322.5 | 237.2 | 14 | 25.27% |

A quarterly filing with NSE carries a profit and loss only. There is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure in this dataset. EPS is restated onto the split-adjusted basis the price series uses; every rupee figure is exactly as filed.

## Shareholding

As filed for 2026-06-30:

- Promoter: 75%
- Public: 25%
- FII: 4.79%, DII: 7.8%
- Promoter shares pledged: 0%

## Recent filings

- 2026-08-03: results for 2026-06-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_181922_03082026203608_iXBRL_WEB.html
- 2026-07-16: shareholding for 2026-06-30 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1693743_16072026094817_WEB.xml
- 2026-05-29: dividend
- 2026-05-13: results for 2026-03-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_157388_13052026221639_iXBRL_WEB.html
- 2026-04-10: shareholding for 2026-03-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1648858_10042026051156_WEB.xml
- 2026-02-09: results for 2025-12-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_141366_09022026192110_iXBRL_WEB.html
- 2026-01-09: shareholding for 2025-12-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1597735_09012026054849_WEB.xml
- 2025-11-06: results for 2025-09-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_124809_06112025171118_iXBRL_WEB.html

Dated by the day the company broadcast the filing. 115 events are indexed for this instrument.

## About the instrument

- Listed: 1995-01-02 — latest session 2026-09-30 (7,849 sessions)
- ISIN: INE159A01016
- Series: EQ
- Liquidity rank: #731 by 20-day average turnover — not index membership

Delivery figures come from NSE's daily reports and are unavailable for older sessions. Prices are end-of-day, split- and bonus-adjusted, from the eod2 dataset.

## More in Pharmaceuticals & Biotechnology

- [DIVISLAB](https://patternsradar.com/s/DIVISLAB.md) — Divi's Laboratories Limited (Pharmaceuticals & Biotechnology)
- [LAURUSLABS](https://patternsradar.com/s/LAURUSLABS.md) — Laurus Labs Limited (Pharmaceuticals & Biotechnology)
- [WOCKPHARMA](https://patternsradar.com/s/WOCKPHARMA.md) — Wockhardt Limited (Pharmaceuticals & Biotechnology)
- [SUNPHARMA](https://patternsradar.com/s/SUNPHARMA.md) — Sun Pharmaceutical Industries Limited (Pharmaceuticals & Biotechnology)
- [MOREPENLAB](https://patternsradar.com/s/MOREPENLAB.md) — Morepen Laboratories Limited (Pharmaceuticals & Biotechnology)
- [DRREDDY](https://patternsradar.com/s/DRREDDY.md) — Dr. Reddy's Laboratories Limited (Pharmaceuticals & Biotechnology)
- [SYMBIOTEC](https://patternsradar.com/s/SYMBIOTEC.md) — SYMBIOTEC (Pharmaceuticals & Biotechnology)
- [GLAND](https://patternsradar.com/s/GLAND.md) — Gland Pharma Limited (Pharmaceuticals & Biotechnology)
- [ZYDUSLIFE](https://patternsradar.com/s/ZYDUSLIFE.md) — Zydus Lifesciences Limited (Pharmaceuticals & Biotechnology)
- [TORNTPHARM](https://patternsradar.com/s/TORNTPHARM.md) — Torrent Pharmaceuticals Limited (Pharmaceuticals & Biotechnology)
- [LUPIN](https://patternsradar.com/s/LUPIN.md) — Lupin Limited (Pharmaceuticals & Biotechnology)
- [AHCL](https://patternsradar.com/s/AHCL.md) — Anlon Healthcare Limited (Pharmaceuticals & Biotechnology)

[All Pharmaceuticals & Biotechnology stocks on the NSE](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md) · [All Healthcare stocks on the NSE](https://patternsradar.com/stocks/sector/healthcare.md)

Charts and the full bar history are on the rendered page: https://patternsradar.com/s/GLAXO.

---

Price and delivery data from the [eod2](https://github.com/BennyThadikaran/eod2) dataset: National Stock Exchange of India end-of-day files, split- and bonus-adjusted, updated after each close. Not affiliated with or endorsed by NSE. PatternsRadar is a research tool. Nothing here is investment advice or a recommendation to buy or sell anything.